Position in PFE
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$2,126,023
-$619,639 QoQ
Shares Held
88,290
-9.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#933
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EASTERN BANK holds $295,354,591 across 16 Drug Manufacturers - General names. PFE ranks #6 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
116,336 | $139,536,899 | |
| 2 | ABBV |
AbbVie Inc.
|
318,655 | $80,186,344 | |
| 3 | JNJ |
Johnson & Johnson
|
145,368 | $36,919,110 | |
| 4 | MRK |
Merck & Co., Inc.
|
191,760 | $24,641,159 | |
| 5 | NVO |
Novo Nordisk A S
|
122,583 | $5,876,628 | |
| 6 | PFE |
Pfizer Inc
This page
|
88,290 | $2,126,023 | |
| 7 | AMGN |
Amgen Inc
|
4,449 | $1,611,071 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
27,740 | $1,598,378 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,126,023 | 88,290 | Shares | Defined | 2026-07-01 | |
| 2026-03-31 | $2,745,662 | 97,780 | Shares | Defined | 2026-04-07 | |
| 2025-12-31 | $2,481,558 | 99,661 | Shares | Defined | 2026-01-14 | |
| 2025-09-30 | $2,563,440 | 100,606 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $2,227,922 | 91,911 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $2,455,039 | 96,884 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $2,582,403 | 97,339 | Shares | Defined | 2025-01-13 | |
| 2024-09-30 | $3,110,065 | 107,466 | Shares | Defined | 2024-10-21 | |
| 2024-06-30 | $517,181 | 18,484 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $586,218 | 21,125 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $672,073 | 23,344 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $797,108 | 24,031 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $883,291 | 24,081 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $1,056,842 | 25,903 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $4,535,558 | 88,516 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $4,023,337 | 91,941 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $5,379,736 | 102,608 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $6,370,867 | 123,061 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $8,234,935 | 139,457 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $6,014,302 | 139,835 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $5,334,805 | 136,231 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $4,919,018 | 135,772 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $5,340,873 | 145,093 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $5,255,801 | 143,210 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $4,462,540 | 136,469 | Shares | Sole | 2020-09-01 | |
| 2020-03-31 | $4,456,561 | 136,537 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||